Cellular immunotherapy strategies for Ewing sarcoma.

about

Wnt/β-catenin pathway in bone cancers.Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma.Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.

P2860

Q34663910-AE354E5B-A04B-450B-8D33-0D9B91BB74B7 Q38784430-A87738E9-251A-4A35-BBEA-417DE66DEC6E Q54105269-54E616DC-0E96-4EFB-B99F-EE98F06F0633

P2860

Cellular immunotherapy strategies for Ewing sarcoma.

Item

http://www.wikidata.org/entity/Q38217594

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cellular immunotherapy strategies for Ewing sarcoma.

@en

type

Item

label

Cellular immunotherapy strategies for Ewing sarcoma.

@en

prefLabel

Cellular immunotherapy strategies for Ewing sarcoma.

@en

P1476

Cellular immunotherapy strategies for Ewing sarcoma.

@en

P2093

Claudia Rossig

http://www.w3.org/2001/XMLSchema#string

P2860

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors

Hallmarks of Cancer: The Next Generation

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes

The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

P304

611-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.14.36

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24896629

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Cellular immunotherapy strategies for Ewing sarcoma.

about

P2860

P2860

Cellular immunotherapy strategies for Ewing sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921